Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAR-T for Recurrent or Refractory Acute Non-T Lymphocyte Leukemia
NCT02735291Phase 2Active, not recruiting
- Sponsor
- Sinobioway Group Co., Ltd.
- Start
- Nov 2015
- Primary completion
- Dec 2019
- Modality
- Gene Editing, Prophylactic Vaccines, Gene Silencing
- Countries
- 1
01
Overview
A Phase 2 trial of Sino19 in acute lymphoblastic leukemia (ALL), sponsored by Sinobioway Group Co., Ltd.. Started Nov 2015; status: active, not recruiting.
02
Drugs
Sino19
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT02735291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02735291.